Koga Y - Search Results

1

Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.

Kumashiro R, Koga Y, Kuwahara R, Ide T, Hino T, Tanaka K, Hisamochi A, Ogata K, Takao Y, Koga H, Nishida H, Okuda S, Sakamoto T, Sata M. Kumashiro R, et al. Among authors: koga h, koga y. Hepatol Res. 2006 Nov;36(3):229-36. doi: 10.1016/j.hepres.2006.06.016. Epub 2006 Sep 1. Hepatol Res. 2006. PMID: 16949861

2

Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene.

Kumashiro R, Kubota T, Koga Y, Tanaka M, Inada C, Kusaba N, Yoshida H, Hisamochi A, Ide T, Tomita Y, Masumoto N, Tanikawa K, Iga T, Sata M. Kumashiro R, et al. Among authors: koga y. Hepatol Res. 2003 Aug;26(4):337-342. doi: 10.1016/s1386-6346(03)00165-7. Hepatol Res. 2003. PMID: 12963435

3

Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.

Kumashiro R, Kuwahara R, Ide T, Koga Y, Arinaga T, Hisamochi A, Ogata K, Tanaka K, Sata M. Kumashiro R, et al. Among authors: koga y. Intervirology. 2003;46(6):350-4. doi: 10.1159/000074991. Intervirology. 2003. PMID: 14688451

4

Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report.

Tsuji Y, Kumashiro R, Ishii K, Arinaga T, Sakamoto Y, Tanabe R, Ogata K, Koga Y, Ide T, Ono N, Tanaka E, Abe H, Sata M. Tsuji Y, et al. Among authors: koga y. Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):26S-31S. doi: 10.1097/01.ALC.0000078607.32247.9D. Alcohol Clin Exp Res. 2003. PMID: 12960503

5

Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.

Hino T, Kumashiro R, Ide T, Koga Y, Ishii K, Tanaka E, Morita Y, Hisamochi A, Murashima S, Tanaka K, Ogata K, Kuwahara R, Sata M; Autoimmune Hepatitis Study Group. Hino T, et al. Among authors: koga y. Int J Mol Med. 2003 Jun;11(6):749-55. Int J Mol Med. 2003. PMID: 12736717

6

Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels.

Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, Sata M. Ide T, et al. Among authors: koga y. Hepatol Res. 2002 Feb;22(2):145-151. doi: 10.1016/s1386-6346(01)00127-9. Hepatol Res. 2002. PMID: 11818254

7

A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.

Ide T, Okamura T, Kumashiro R, Koga Y, Hino T, Hisamochi A, Ogata K, Tanaka K, Kuwahara R, Seki R, Sata M. Ide T, et al. Among authors: koga y. Int J Mol Med. 2003 Jun;11(6):729-32. Int J Mol Med. 2003. PMID: 12736713

8

Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment.

Ide T, Kumashiro R, Kuwahara R, Koga H, Koga Y, Hino T, Tanaka K, Hisamochi A, Ogata K, Sata M; Hepatitis B study group. Ide T, et al. Among authors: koga h, koga y. J Gastroenterol. 2005 Jun;40(6):625-30. doi: 10.1007/s00535-005-1597-9. J Gastroenterol. 2005. PMID: 16007397

9

A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.

Ide T, Kumashiro R, Koga Y, Tanaka E, Hino T, Hisamochi A, Murashima S, Ogata K, Tanaka K, Kuwahara R, Sata M. Ide T, et al. Among authors: koga y. Am J Gastroenterol. 2003 Sep;98(9):2048-51. doi: 10.1111/j.1572-0241.2003.07643.x. Am J Gastroenterol. 2003. PMID: 14499786

10

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.

Kuwahara R, Kumashiro R, Murashima S, Ogata K, Tanaka K, Hisamochi A, Hino T, Ide T, Tanaka E, Koga Y, Sata M. Kuwahara R, et al. Among authors: koga y. J Med Virol. 2004 Jan;72(1):26-34. doi: 10.1002/jmv.10558. J Med Virol. 2004. PMID: 14635007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results